semaglutide compounding Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots Addressing the Weight Loss Injectable

FDA described insufficient clinical safety information, characterisation concerns and inadequate evidence of effectiveness for its reviewed use

With population growth, longevity is a big positive for the food industry over time. The two said the CPG manufacturers theyve talked to about the longevity dividend are gathering information and surveying consumers to determine where the puck is going next as far as new products that will appeal to those taking GLP-1s

doi: 10.3389/fmolb.2025.1727385 Palacios S

Blood flow to deep hip structures remains limited compared to more superficial tissues

I've tried it all." The Greenwood mom lost 12 pounds on Zepbound, a name-brand GLP-1

National Institutes of Health (US), Office of Dietary Supplements